Execution Time Definition Example

At The Market Offering Agreement by and between Xenetic Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated November 19, 2021 (Filed With SEC on November 19, 2021)

At the Market Offering Agreement by and between Greenland Technologies Holding Corporation and H.C. Wainwright & Co., LLC, dated November 19, 2021 (Filed With SEC on November 22, 2021)

At The Market Offering Agreement, dated December 10, 2021, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on December 10, 2021)

At the Market Offering Agreement, dated March 4, 2022, between NextPlay Technologies, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on March 4, 2022)

At The Market Offering Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated March 22, 2022 (Filed With SEC on March 22, 2022)

At the Market Offering Agreement, dated March 24, 2022, by and between Aethlon Medical, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on March 24, 2022)

At the Market Offering Agreement dated April 7, 2021 by and between InMed Pharmaceuticals Inc., and H.C. Wainwright & Co., LLC (Filed With SEC on April 7, 2022)

At the Market Offering Agreement (Filed With SEC on May 6, 2022)

At The Market Offering Agreement, dated January 31, 2023, by and between Nuvve Holding Corp. and Craig-Hallum Capital Group LLC (Filed With SEC on January 31, 2023)

At the Market Offering Agreement, dated June 24, 2022, by and between OpGen, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on June 24, 2022)

At the Market Offering Agreement dated February 24, 2023, by and among Oragenics, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on February 24, 2023)

At the Market Offering Agreement dated November 2, 2018 (Filed With SEC on November 2, 2018)

At-the-Market Offering Agreement, dated March 29, 2023 (Filed With SEC on March 29, 2023)

At The Market Offering Agreement, dated June 7, 2018, between Capstone Turbine Corporation and H.C. Wainwright & Co., LLC (Filed With SEC on June 7, 2018)

AT THE MARKET OFFERING AGREEMENT December 20, 2016 (Filed With SEC on December 20, 2016)

At the Market Offering Agreement, dated February 16, 2017, by and between Pro-Dex, Inc. and Ascendiant Capital Markets, LLC (Filed With SEC on February 16, 2017)

At The Market Offering Agreement, dated as of November 9, 2023, by and between Windtree Therapeutics, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on November 9, 2023)

At The Market Offering Agreement, dated June 2, 2023, between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on June 2, 2023)

At The Market Offering Agreement, dated February 1, 2024, by and between Inhibikase Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on February 1, 2024)

At The Market Offering Agreement, dated October 23, 2023, by and between HeartCore Enterprises, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on October 23, 2023)

At The Market Offering Agreement between MAIA Biotechnology, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on February 14, 2024)

At the Market Offering Agreement by and between Cadrenal Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on March 12, 2024)

At the Market Offering Agreement, dated March 20, 2024, by and between Know Labs, Inc. and The Benchmark Company, LLC (Filed With SEC on March 20, 2024)

At The Market Offering Agreement, by and between Bio-Path Holdings, Inc. and H.C. Wainwright & Co., LLC, dated April 4, 2024 (Filed With SEC on April 4, 2024)